Quizartinib is a small molecule receptor tyrosine kinase inhibitor.
The global Quizartinib market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Quizartinib selectively inhibits class III receptor tyrosine kinases, including FMS-related tyrosine kinase 3, colony-stimulating factor 1 receptor, stem cell factor receptor, and platelet derived growth factor receptors.
In terms of production side, this report researches the Quizartinib production, growth rate, market share by manufacturers and by region (region level and country level), from 2018 to 2023, and forecast to 2029.
In terms of consumption side, this report focuses on the sales of Quizartinib by region (region level and country level), by company, by Type and by Application. from 2018 to 2023 and forecast to 2029.
Report Includes:
This report presents an overview of global market for Quizartinib, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Quizartinib, also provides the consumption of main regions and countries. Highlights of the upcoming market potential for Quizartinib, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Quizartinib sales, revenue, market share and industry ranking of main manufacturers, data from 2018 to 2023. Identification of the major stakeholders in the global Quizartinib market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2018 to 2029. Evaluation and forecast the market size for Quizartinib sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including AdipoGen Life Sciences, Inc., APExBIO Technology LLC, Biorbyt Ltd., BioVision,Inc., Cayman Chemical Company, Enzo Biochem Inc., MedChemExpress (MCE), Selleck Chemicals and Target Molecule Corp., etc.
By Company
AdipoGen Life Sciences, Inc.
APExBIO Technology LLC
Biorbyt Ltd.
BioVision,Inc.
Cayman Chemical Company
Enzo Biochem Inc.
MedChemExpress (MCE)
Selleck Chemicals
Target Molecule Corp.
Segment by Type
Solution
Powder
Segment by Application
Research Laboratory
Hospital
Others
Production by Region
North America
Europe
China
Japan
Sales by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Quizartinib production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production and development potential of each producer in the next six years.
Chapter 3: Sales (consumption), revenue of Quizartinib in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Quizartinib manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by type, by application and by country, sales and revenue for each segment.
Chapter 8: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 9: China by type and by application sales and revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, sales and revenue for each segment.
Chapter 11: Middle East, Africa, Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 12: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Quizartinib sales, revenue, price, gross margin, and recent development, etc.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 15: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Study Coverage
1.1 Quizartinib Product Introduction
1.2 Market by Type
1.2.1 Global Quizartinib Market Size by Type, 2018 VS 2022 VS 2029
1.2.2 Solution
1.2.3 Powder
1.3 Market by Application
1.3.1 Global Quizartinib Market Size by Application, 2018 VS 2022 VS 2029
1.3.2 Research Laboratory
1.3.3 Hospital
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Quizartinib Production
2.1 Global Quizartinib Production Capacity (2018-2029)
2.2 Global Quizartinib Production by Region: 2018 VS 2022 VS 2029
2.3 Global Quizartinib Production by Region
2.3.1 Global Quizartinib Historic Production by Region (2018-2023)
2.3.2 Global Quizartinib Forecasted Production by Region (2024-2029)
2.3.3 Global Quizartinib Production Market Share by Region (2018-2029)
2.4 North America
2.5 Europe
2.6 China
2.7 Japan
3 Executive Summary
3.1 Global Quizartinib Revenue Estimates and Forecasts 2018-2029
3.2 Global Quizartinib Revenue by Region
3.2.1 Global Quizartinib Revenue by Region: 2018 VS 2022 VS 2029
3.2.2 Global Quizartinib Revenue by Region (2018-2023)
3.2.3 Global Quizartinib Revenue by Region (2024-2029)
3.2.4 Global Quizartinib Revenue Market Share by Region (2018-2029)
3.3 Global Quizartinib Sales Estimates and Forecasts 2018-2029
3.4 Global Quizartinib Sales by Region
3.4.1 Global Quizartinib Sales by Region: 2018 VS 2022 VS 2029
3.4.2 Global Quizartinib Sales by Region (2018-2023)
3.4.3 Global Quizartinib Sales by Region (2024-2029)
3.4.4 Global Quizartinib Sales Market Share by Region (2018-2029)
3.5 US & Canada
3.6 Europe
3.7 China
3.8 Asia (excluding China)
3.9 Middle East, Africa and Latin America
4 Competition by Manufactures
4.1 Global Quizartinib Sales by Manufacturers
4.1.1 Global Quizartinib Sales by Manufacturers (2018-2023)
4.1.2 Global Quizartinib Sales Market Share by Manufacturers (2018-2023)
4.1.3 Global Top 10 and Top 5 Largest Manufacturers of Quizartinib in 2022
4.2 Global Quizartinib Revenue by Manufacturers
4.2.1 Global Quizartinib Revenue by Manufacturers (2018-2023)
4.2.2 Global Quizartinib Revenue Market Share by Manufacturers (2018-2023)
4.2.3 Global Top 10 and Top 5 Companies by Quizartinib Revenue in 2022
4.3 Global Quizartinib Sales Price by Manufacturers
4.4 Global Key Players of Quizartinib, Industry Ranking, 2021 VS 2022 VS 2023
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Quizartinib Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.6 Global Key Manufacturers of Quizartinib, Manufacturing Base Distribution and Headquarters
4.7 Global Key Manufacturers of Quizartinib, Product Offered and Application
4.8 Global Key Manufacturers of Quizartinib, Date of Enter into This Industry
4.9 Mergers & Acquisitions, Expansion Plans
5 Market Size by Type
5.1 Global Quizartinib Sales by Type
5.1.1 Global Quizartinib Historical Sales by Type (2018-2023)
5.1.2 Global Quizartinib Forecasted Sales by Type (2024-2029)
5.1.3 Global Quizartinib Sales Market Share by Type (2018-2029)
5.2 Global Quizartinib Revenue by Type
5.2.1 Global Quizartinib Historical Revenue by Type (2018-2023)
5.2.2 Global Quizartinib Forecasted Revenue by Type (2024-2029)
5.2.3 Global Quizartinib Revenue Market Share by Type (2018-2029)
5.3 Global Quizartinib Price by Type
5.3.1 Global Quizartinib Price by Type (2018-2023)
5.3.2 Global Quizartinib Price Forecast by Type (2024-2029)
6 Market Size by Application
6.1 Global Quizartinib Sales by Application
6.1.1 Global Quizartinib Historical Sales by Application (2018-2023)
6.1.2 Global Quizartinib Forecasted Sales by Application (2024-2029)
6.1.3 Global Quizartinib Sales Market Share by Application (2018-2029)
6.2 Global Quizartinib Revenue by Application
6.2.1 Global Quizartinib Historical Revenue by Application (2018-2023)
6.2.2 Global Quizartinib Forecasted Revenue by Application (2024-2029)
6.2.3 Global Quizartinib Revenue Market Share by Application (2018-2029)
6.3 Global Quizartinib Price by Application
6.3.1 Global Quizartinib Price by Application (2018-2023)
6.3.2 Global Quizartinib Price Forecast by Application (2024-2029)
7 US & Canada
7.1 US & Canada Quizartinib Market Size by Type
7.1.1 US & Canada Quizartinib Sales by Type (2018-2029)
7.1.2 US & Canada Quizartinib Revenue by Type (2018-2029)
7.2 US & Canada Quizartinib Market Size by Application
7.2.1 US & Canada Quizartinib Sales by Application (2018-2029)
7.2.2 US & Canada Quizartinib Revenue by Application (2018-2029)
7.3 US & Canada Quizartinib Sales by Country
7.3.1 US & Canada Quizartinib Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 US & Canada Quizartinib Sales by Country (2018-2029)
7.3.3 US & Canada Quizartinib Revenue by Country (2018-2029)
7.3.4 U.S.
7.3.5 Canada
8 Europe
8.1 Europe Quizartinib Market Size by Type
8.1.1 Europe Quizartinib Sales by Type (2018-2029)
8.1.2 Europe Quizartinib Revenue by Type (2018-2029)
8.2 Europe Quizartinib Market Size by Application
8.2.1 Europe Quizartinib Sales by Application (2018-2029)
8.2.2 Europe Quizartinib Revenue by Application (2018-2029)
8.3 Europe Quizartinib Sales by Country
8.3.1 Europe Quizartinib Revenue by Country: 2018 VS 2022 VS 2029
8.3.2 Europe Quizartinib Sales by Country (2018-2029)
8.3.3 Europe Quizartinib Revenue by Country (2018-2029)
8.3.4 Germany
8.3.5 France
8.3.6 U.K.
8.3.7 Italy
8.3.8 Russia
9 China
9.1 China Quizartinib Market Size by Type
9.1.1 China Quizartinib Sales by Type (2018-2029)
9.1.2 China Quizartinib Revenue by Type (2018-2029)
9.2 China Quizartinib Market Size by Application
9.2.1 China Quizartinib Sales by Application (2018-2029)
9.2.2 China Quizartinib Revenue by Application (2018-2029)
10 Asia (excluding China)
10.1 Asia Quizartinib Market Size by Type
10.1.1 Asia Quizartinib Sales by Type (2018-2029)
10.1.2 Asia Quizartinib Revenue by Type (2018-2029)
10.2 Asia Quizartinib Market Size by Application
10.2.1 Asia Quizartinib Sales by Application (2018-2029)
10.2.2 Asia Quizartinib Revenue by Application (2018-2029)
10.3 Asia Quizartinib Sales by Region
10.3.1 Asia Quizartinib Revenue by Region: 2018 VS 2022 VS 2029
10.3.2 Asia Quizartinib Revenue by Region (2018-2029)
10.3.3 Asia Quizartinib Sales by Region (2018-2029)
10.3.4 Japan
10.3.5 South Korea
10.3.6 China Taiwan
10.3.7 Southeast Asia
10.3.8 India
11 Middle East, Africa and Latin America
11.1 Middle East, Africa and Latin America Quizartinib Market Size by Type
11.1.1 Middle East, Africa and Latin America Quizartinib Sales by Type (2018-2029)
11.1.2 Middle East, Africa and Latin America Quizartinib Revenue by Type (2018-2029)
11.2 Middle East, Africa and Latin America Quizartinib Market Size by Application
11.2.1 Middle East, Africa and Latin America Quizartinib Sales by Application (2018-2029)
11.2.2 Middle East, Africa and Latin America Quizartinib Revenue by Application (2018-2029)
11.3 Middle East, Africa and Latin America Quizartinib Sales by Country
11.3.1 Middle East, Africa and Latin America Quizartinib Revenue by Country: 2018 VS 2022 VS 2029
11.3.2 Middle East, Africa and Latin America Quizartinib Revenue by Country (2018-2029)
11.3.3 Middle East, Africa and Latin America Quizartinib Sales by Country (2018-2029)
11.3.4 Brazil
11.3.5 Mexico
11.3.6 Turkey
11.3.7 Israel
11.3.8 GCC Countries
12 Corporate Profiles
12.1 AdipoGen Life Sciences, Inc.
12.1.1 AdipoGen Life Sciences, Inc. Company Information
12.1.2 AdipoGen Life Sciences, Inc. Overview
12.1.3 AdipoGen Life Sciences, Inc. Quizartinib Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.1.4 AdipoGen Life Sciences, Inc. Quizartinib Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 AdipoGen Life Sciences, Inc. Recent Developments
12.2 APExBIO Technology LLC
12.2.1 APExBIO Technology LLC Company Information
12.2.2 APExBIO Technology LLC Overview
12.2.3 APExBIO Technology LLC Quizartinib Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.2.4 APExBIO Technology LLC Quizartinib Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 APExBIO Technology LLC Recent Developments
12.3 Biorbyt Ltd.
12.3.1 Biorbyt Ltd. Company Information
12.3.2 Biorbyt Ltd. Overview
12.3.3 Biorbyt Ltd. Quizartinib Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.3.4 Biorbyt Ltd. Quizartinib Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 Biorbyt Ltd. Recent Developments
12.4 BioVision,Inc.
12.4.1 BioVision,Inc. Company Information
12.4.2 BioVision,Inc. Overview
12.4.3 BioVision,Inc. Quizartinib Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.4.4 BioVision,Inc. Quizartinib Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 BioVision,Inc. Recent Developments
12.5 Cayman Chemical Company
12.5.1 Cayman Chemical Company Company Information
12.5.2 Cayman Chemical Company Overview
12.5.3 Cayman Chemical Company Quizartinib Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.5.4 Cayman Chemical Company Quizartinib Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 Cayman Chemical Company Recent Developments
12.6 Enzo Biochem Inc.
12.6.1 Enzo Biochem Inc. Company Information
12.6.2 Enzo Biochem Inc. Overview
12.6.3 Enzo Biochem Inc. Quizartinib Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.6.4 Enzo Biochem Inc. Quizartinib Product Model Numbers, Pictures, Descriptions and Specifications
12.6.5 Enzo Biochem Inc. Recent Developments
12.7 MedChemExpress (MCE)
12.7.1 MedChemExpress (MCE) Company Information
12.7.2 MedChemExpress (MCE) Overview
12.7.3 MedChemExpress (MCE) Quizartinib Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.7.4 MedChemExpress (MCE) Quizartinib Product Model Numbers, Pictures, Descriptions and Specifications
12.7.5 MedChemExpress (MCE) Recent Developments
12.8 Selleck Chemicals
12.8.1 Selleck Chemicals Company Information
12.8.2 Selleck Chemicals Overview
12.8.3 Selleck Chemicals Quizartinib Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.8.4 Selleck Chemicals Quizartinib Product Model Numbers, Pictures, Descriptions and Specifications
12.8.5 Selleck Chemicals Recent Developments
12.9 Target Molecule Corp.
12.9.1 Target Molecule Corp. Company Information
12.9.2 Target Molecule Corp. Overview
12.9.3 Target Molecule Corp. Quizartinib Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.9.4 Target Molecule Corp. Quizartinib Product Model Numbers, Pictures, Descriptions and Specifications
12.9.5 Target Molecule Corp. Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 Quizartinib Industry Chain Analysis
13.2 Quizartinib Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Quizartinib Production Mode & Process
13.4 Quizartinib Sales and Marketing
13.4.1 Quizartinib Sales Channels
13.4.2 Quizartinib Distributors
13.5 Quizartinib Customers
14 Quizartinib Market Dynamics
14.1 Quizartinib Industry Trends
14.2 Quizartinib Market Drivers
14.3 Quizartinib Market Challenges
14.4 Quizartinib Market Restraints
15 Key Finding in The Global Quizartinib Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
AdipoGen Life Sciences, Inc.
APExBIO Technology LLC
Biorbyt Ltd.
BioVision,Inc.
Cayman Chemical Company
Enzo Biochem Inc.
MedChemExpress (MCE)
Selleck Chemicals
Target Molecule Corp.
*If Applicable.